![Yun Xia Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yun Xia Yang
Directeur/Membre du Conseil chez
CUTIA THERAPEUTICS
Profil
Yun Xia Yang is currently Director at Xiamen LP Pharmaceutical Co., Ltd. since 2020, Director at AccuMedical Beijing Co., Ltd. since 2022, Director at Qianglian Zhichuang (Beijing) Technology Co., Ltd., Director at Jiutian Biopharmaceutical (Shanghai) Co., Ltd., Director at Cutia Therapeutics (Shanghai) Co., Ltd., and Non-Executive Director at Cutia Therapeutics since 2022.
Former positions include Director at Adagene, Inc. from 2019 to 2021, Director at Burning Rock Biotech Ltd. from 2017 to 2022, Vice President at Legend Capital Co. Ltd. from 2011 to 2015, Product Manager at GE Healthcare (China) Co. Ltd., Manager-Business Development at Johnson & Johnson China Ltd. from 2009 to 2011, and Partner at Sequoia Capital China Investment Management LP.
Education includes an MBA from Duke University conferred in 2009, and graduate degrees from Huazhong University of Science & Technology and Tongji Medical College of Huazhong University of Science & Technology both conferred in 1997.
Postes actifs de Yun Xia Yang
| Sociétés | Poste | Début |
|---|---|---|
| CUTIA THERAPEUTICS | Directeur/Membre du Conseil | 26/08/2020 |
Xiamen LP Pharmaceutical Co., Ltd.
 Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures drug delivery systems and pharmaceutical products | Directeur/Membre du Conseil | 31/08/2020 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Directeur/Membre du Conseil | - |
AccuMedical Beijing Co., Ltd.
 AccuMedical Beijing Co., Ltd. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Directeur/Membre du Conseil | 09/06/2022 |
Jiutian Biopharmaceutical (Shanghai) Co., Ltd.
 Jiutian Biopharmaceutical (Shanghai) Co., Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Qianglian Zhichuang (Beijing) Technology Co., Ltd.
 Qianglian Zhichuang (Beijing) Technology Co., Ltd. Hospital/Nursing ManagementHealth Services Provides intelligent auxiliary diagnosis and treatment solutions for neurological diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Yun Xia Yang
| Sociétés | Poste | Fin |
|---|---|---|
| BURNING ROCK BIOTECH LIMITED | Directeur/Membre du Conseil | 14/07/2022 |
| ADAGENE INC. | Directeur/Membre du Conseil | 08/02/2021 |
Legend Capital Co. Ltd.
 Legend Capital Co. Ltd. Investment ManagersFinance Legend Capital invests in companies located in China. The firm targets companies operating in the fields of technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. It provides financing for early and growth stage capital requirements. | Corporate Officer/Principal | 01/05/2015 |
| ░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Yun Xia Yang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Huazhong University of Science & Technology
 Huazhong University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Legend Capital Co. Ltd.
Legend Capital Co. Ltd. Investment ManagersFinance Legend Capital invests in companies located in China. The firm targets companies operating in the fields of technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. It provides financing for early and growth stage capital requirements. | Finance |
GE Healthcare (China) Co. Ltd. | |
Tongji Medical College of Huazhong University of Sci & Tech
 Tongji Medical College of Huazhong University of Sci & Tech Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adagene, Inc.
 Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
Johnson & Johnson China Ltd.
 Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Sequoia Capital China Investment Management LP
 Sequoia Capital China Investment Management LP Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures drug delivery systems and pharmaceutical products | Commercial Services |
Burning Rock Biotech Ltd.
 Burning Rock Biotech Ltd. Medical/Nursing ServicesHealth Services Specializes in diagnostics solutions for precision medicine in oncology | Health Services |
AccuMedical Beijing Co., Ltd.
AccuMedical Beijing Co., Ltd. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Health Technology |
Qianglian Zhichuang (Beijing) Technology Co., Ltd.
Qianglian Zhichuang (Beijing) Technology Co., Ltd. Hospital/Nursing ManagementHealth Services Provides intelligent auxiliary diagnosis and treatment solutions for neurological diseases | Health Services |
Jiutian Biopharmaceutical (Shanghai) Co., Ltd.
Jiutian Biopharmaceutical (Shanghai) Co., Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Health Technology |
Cutia Therapeutics
 Cutia Therapeutics Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing and marketing of dermatology based biopharmaceutical products | Health Technology |
Choisissez Zonebourse 
